LYCOS RETRIEVER 
Merck: Drugs
built 650 days ago
Merck Generics offers affordable standard therapies in nearly all major therapeutic areas through high-quality drugs containing active ingredients that are no longer patent protected. The range of products includes a wide assortment of more than 400 different substances plus special dosage forms and delivery systems with high patient benefit.
Source:
The Federal Trade Commission today announced an agreement with Merck and Co., Inc. ("Merck"), a leading pharmaceutical manufacturer, and its subsidiary, Merck-Medco Managed Care, LLC (“Medco”), resolving antitrust concerns resulting from Merck’s acquisition of Medco. The Commission alleged that Merck’s acquisition of Medco, a pharmacy benefits manager (“PBM”), may substantially lessen competition in the manufacture and sale of pharmaceuticals, and in the provision of PBM services, leading to higher prices and reduced quality. PBMs serve as middlemen in the provision of prescription drugs to managed care plans. The settlement would require Medco to take steps to diminish the effects of any unwarranted preference that might be given to Merck’s drugs over those of Merck’s competitors in connection with the pharmacy benefit management services that it provides.
Source:
It's not just Merck that is getting off cheap. Another potential tort was for the schizophrenia drug Zyprexa, which causes more weight gain--and, potentially, diabetes--than its peers. But Eli Lilly (nyse: LLY - news - people ) has settled 30,000 claims for a little more than $1 billion. Zyprexa generates $4 billion in sales a year.
Source:
The proposed consent agreement, which was announced today for public comment, would require Merck-Medco to maintain an “open formulary” -- one that includes drugs selected and approved by an independent Pharmacy and Therapeutics ("P&T") Committee. This committee would consist of physicians and pharmacologists who have no financial interest in Merck. The consent order would require that this P&T Committee independently make all decisions concerning the inclusion and exclusion of drugs on the open formulary.
Source:
The primary faculty involved in the Merck/AAAS undergraduate research program at Fredonia are Dr. Fountain (biology and chemistry), Dr. Lee (biology), Dr. Pamela Marshall (biology), Dr. Philip Kumler (chemistry), Dr. Mark Janik (chemistry), and Dr. Holly Lawson (chemistry). The research projects of these faculty ranges from gene expression and cloning to structural biology and anti-cancer drug design.
Source:
McDarby's attorney, Robert Gordon, told jurors that Braun got 220 visits from 17 Merck sales representatives about Vioxx between 1999 and 2004. Jurors heard testimony this week that thousands of sales representatives gave away millions of free samples of Vioxx during the biggest drug launch campaign in the history of Merck.
Source:
MORE ABOUT
Drugs